Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps
Hypertonic solutions of dextrose (D), mannitol (M), and saline (S) are effective treatments for hemodialysis-associated muscle cramps, but have not been directly compared to one another. Concern exists that postdialysis retention of M and S may lead to increased thirst, interdialytic weight pain (ID...
Gespeichert in:
Veröffentlicht in: | ASAIO transactions 1991-10, Vol.37 (4), p.649-652 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 652 |
---|---|
container_issue | 4 |
container_start_page | 649 |
container_title | ASAIO transactions |
container_volume | 37 |
creator | CANZANELLO, V. J HYLANDER-ROSSNER, B SANDS, R. E MORGAN, T. M JORDAN, J BURKART, J. M |
description | Hypertonic solutions of dextrose (D), mannitol (M), and saline (S) are effective treatments for hemodialysis-associated muscle cramps, but have not been directly compared to one another. Concern exists that postdialysis retention of M and S may lead to increased thirst, interdialytic weight pain (IDWG), and elevated blood pressure. The authors performed a prospective, randomized, double-blind crossover study to compare the efficacy of D, M, and S in 24 chronic hemodialysis patients. Cramps were treated with 50 ml (126 mOsm) D, 100 ml (138 mOsm) M, and 16 ml (126 mOsm) S. All patients were assigned to each regimen for a 2 week period. For the entire patient group (n = 24), mean cramp duration (+/- SD) was less for M compared to D (9 +/- 5 vs 13 +/- 12 min, p less than 0.05), but not to S (10 +/- 6, p = NS) although not every patient had a cramp episode during each 2 week period of study. In a subgroup of 11 patients with a mean of 3.7 (range 1-6) cramps during each 2 week period, the efficacy of D, M, and S was similar. In both patient groups, IDWG, blood pressure control, and the frequency of adverse effects was similar with the use of all three agents. Mild postdialysis hyperglycemia and hypernatremia during D and S, respectively, were the only significant laboratory abnormalities. The authors conclude: 1) the safety and efficacy of D, M, and S are equivalent, and 2) the nonmetabolized osmotic agents M and S do not lead to increased IDWG or decreased blood pressure control. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72604755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72604755</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-43d93a582c9df9dc5435a09c44cc0ca8dbd7ee9cf835a8c369d557ca9f1d78223</originalsourceid><addsrcrecordid>eNo9kE1LxDAURYso4zj6E4QsHFdW0qRpmqUMfsGAG12XN0nKRJqm5qXo4J-3YnF14d7DWdyjbMm4FDlVgh1nS1rXKpeFoqfZGeI7pZxLWiyyRSGrWtBymX1vgh8gOgw9CS0RdE2M_UoxoCWfkGy8IUysiYe-dyl0NwR6Qxi_nTqEzvWWtCGStLckRQvJ2z79evbWB-OgO6DDHBCDdpPMED-i7izREfyA59lJCx3aizlX2dvD_evmKd--PD5v7rb5UAia8pIbxUHUTCvTKqNFyQVQpctSa6qhNjsjrVW6rae-1rxSRgipQbWFkTVjfJVd_3mHGD5Gi6nxDrXtOuhtGLGRrKKlFGICL2dw3HlrmiE6D_HQzG9N-9W8A2ro2gi9dviPCUaZqgT_AeE7c9w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72604755</pqid></control><display><type>article</type><title>Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>CANZANELLO, V. J ; HYLANDER-ROSSNER, B ; SANDS, R. E ; MORGAN, T. M ; JORDAN, J ; BURKART, J. M</creator><creatorcontrib>CANZANELLO, V. J ; HYLANDER-ROSSNER, B ; SANDS, R. E ; MORGAN, T. M ; JORDAN, J ; BURKART, J. M</creatorcontrib><description>Hypertonic solutions of dextrose (D), mannitol (M), and saline (S) are effective treatments for hemodialysis-associated muscle cramps, but have not been directly compared to one another. Concern exists that postdialysis retention of M and S may lead to increased thirst, interdialytic weight pain (IDWG), and elevated blood pressure. The authors performed a prospective, randomized, double-blind crossover study to compare the efficacy of D, M, and S in 24 chronic hemodialysis patients. Cramps were treated with 50 ml (126 mOsm) D, 100 ml (138 mOsm) M, and 16 ml (126 mOsm) S. All patients were assigned to each regimen for a 2 week period. For the entire patient group (n = 24), mean cramp duration (+/- SD) was less for M compared to D (9 +/- 5 vs 13 +/- 12 min, p less than 0.05), but not to S (10 +/- 6, p = NS) although not every patient had a cramp episode during each 2 week period of study. In a subgroup of 11 patients with a mean of 3.7 (range 1-6) cramps during each 2 week period, the efficacy of D, M, and S was similar. In both patient groups, IDWG, blood pressure control, and the frequency of adverse effects was similar with the use of all three agents. Mild postdialysis hyperglycemia and hypernatremia during D and S, respectively, were the only significant laboratory abnormalities. The authors conclude: 1) the safety and efficacy of D, M, and S are equivalent, and 2) the nonmetabolized osmotic agents M and S do not lead to increased IDWG or decreased blood pressure control.</description><identifier>ISSN: 0889-7190</identifier><identifier>EISSN: 2375-0952</identifier><identifier>PMID: 1768504</identifier><identifier>CODEN: ASATEJ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Pressure - drug effects ; Double-Blind Method ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Glucose Solution, Hypertonic - therapeutic use ; Humans ; Intensive care medicine ; Male ; Mannitol - therapeutic use ; Medical sciences ; Middle Aged ; Muscle Cramp - drug therapy ; Muscle Cramp - epidemiology ; Muscle Cramp - etiology ; Prospective Studies ; Renal Dialysis - adverse effects ; Saline Solution, Hypertonic - therapeutic use ; Weight Gain - drug effects</subject><ispartof>ASAIO transactions, 1991-10, Vol.37 (4), p.649-652</ispartof><rights>1992 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5202965$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1768504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CANZANELLO, V. J</creatorcontrib><creatorcontrib>HYLANDER-ROSSNER, B</creatorcontrib><creatorcontrib>SANDS, R. E</creatorcontrib><creatorcontrib>MORGAN, T. M</creatorcontrib><creatorcontrib>JORDAN, J</creatorcontrib><creatorcontrib>BURKART, J. M</creatorcontrib><title>Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps</title><title>ASAIO transactions</title><addtitle>ASAIO Trans</addtitle><description>Hypertonic solutions of dextrose (D), mannitol (M), and saline (S) are effective treatments for hemodialysis-associated muscle cramps, but have not been directly compared to one another. Concern exists that postdialysis retention of M and S may lead to increased thirst, interdialytic weight pain (IDWG), and elevated blood pressure. The authors performed a prospective, randomized, double-blind crossover study to compare the efficacy of D, M, and S in 24 chronic hemodialysis patients. Cramps were treated with 50 ml (126 mOsm) D, 100 ml (138 mOsm) M, and 16 ml (126 mOsm) S. All patients were assigned to each regimen for a 2 week period. For the entire patient group (n = 24), mean cramp duration (+/- SD) was less for M compared to D (9 +/- 5 vs 13 +/- 12 min, p less than 0.05), but not to S (10 +/- 6, p = NS) although not every patient had a cramp episode during each 2 week period of study. In a subgroup of 11 patients with a mean of 3.7 (range 1-6) cramps during each 2 week period, the efficacy of D, M, and S was similar. In both patient groups, IDWG, blood pressure control, and the frequency of adverse effects was similar with the use of all three agents. Mild postdialysis hyperglycemia and hypernatremia during D and S, respectively, were the only significant laboratory abnormalities. The authors conclude: 1) the safety and efficacy of D, M, and S are equivalent, and 2) the nonmetabolized osmotic agents M and S do not lead to increased IDWG or decreased blood pressure control.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Double-Blind Method</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Glucose Solution, Hypertonic - therapeutic use</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Mannitol - therapeutic use</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle Cramp - drug therapy</subject><subject>Muscle Cramp - epidemiology</subject><subject>Muscle Cramp - etiology</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - adverse effects</subject><subject>Saline Solution, Hypertonic - therapeutic use</subject><subject>Weight Gain - drug effects</subject><issn>0889-7190</issn><issn>2375-0952</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAURYso4zj6E4QsHFdW0qRpmqUMfsGAG12XN0nKRJqm5qXo4J-3YnF14d7DWdyjbMm4FDlVgh1nS1rXKpeFoqfZGeI7pZxLWiyyRSGrWtBymX1vgh8gOgw9CS0RdE2M_UoxoCWfkGy8IUysiYe-dyl0NwR6Qxi_nTqEzvWWtCGStLckRQvJ2z79evbWB-OgO6DDHBCDdpPMED-i7izREfyA59lJCx3aizlX2dvD_evmKd--PD5v7rb5UAia8pIbxUHUTCvTKqNFyQVQpctSa6qhNjsjrVW6rae-1rxSRgipQbWFkTVjfJVd_3mHGD5Gi6nxDrXtOuhtGLGRrKKlFGICL2dw3HlrmiE6D_HQzG9N-9W8A2ro2gi9dviPCUaZqgT_AeE7c9w</recordid><startdate>199110</startdate><enddate>199110</enddate><creator>CANZANELLO, V. J</creator><creator>HYLANDER-ROSSNER, B</creator><creator>SANDS, R. E</creator><creator>MORGAN, T. M</creator><creator>JORDAN, J</creator><creator>BURKART, J. M</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199110</creationdate><title>Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps</title><author>CANZANELLO, V. J ; HYLANDER-ROSSNER, B ; SANDS, R. E ; MORGAN, T. M ; JORDAN, J ; BURKART, J. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-43d93a582c9df9dc5435a09c44cc0ca8dbd7ee9cf835a8c369d557ca9f1d78223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Double-Blind Method</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Glucose Solution, Hypertonic - therapeutic use</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Mannitol - therapeutic use</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle Cramp - drug therapy</topic><topic>Muscle Cramp - epidemiology</topic><topic>Muscle Cramp - etiology</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - adverse effects</topic><topic>Saline Solution, Hypertonic - therapeutic use</topic><topic>Weight Gain - drug effects</topic><toplevel>online_resources</toplevel><creatorcontrib>CANZANELLO, V. J</creatorcontrib><creatorcontrib>HYLANDER-ROSSNER, B</creatorcontrib><creatorcontrib>SANDS, R. E</creatorcontrib><creatorcontrib>MORGAN, T. M</creatorcontrib><creatorcontrib>JORDAN, J</creatorcontrib><creatorcontrib>BURKART, J. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>ASAIO transactions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CANZANELLO, V. J</au><au>HYLANDER-ROSSNER, B</au><au>SANDS, R. E</au><au>MORGAN, T. M</au><au>JORDAN, J</au><au>BURKART, J. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps</atitle><jtitle>ASAIO transactions</jtitle><addtitle>ASAIO Trans</addtitle><date>1991-10</date><risdate>1991</risdate><volume>37</volume><issue>4</issue><spage>649</spage><epage>652</epage><pages>649-652</pages><issn>0889-7190</issn><eissn>2375-0952</eissn><coden>ASATEJ</coden><abstract>Hypertonic solutions of dextrose (D), mannitol (M), and saline (S) are effective treatments for hemodialysis-associated muscle cramps, but have not been directly compared to one another. Concern exists that postdialysis retention of M and S may lead to increased thirst, interdialytic weight pain (IDWG), and elevated blood pressure. The authors performed a prospective, randomized, double-blind crossover study to compare the efficacy of D, M, and S in 24 chronic hemodialysis patients. Cramps were treated with 50 ml (126 mOsm) D, 100 ml (138 mOsm) M, and 16 ml (126 mOsm) S. All patients were assigned to each regimen for a 2 week period. For the entire patient group (n = 24), mean cramp duration (+/- SD) was less for M compared to D (9 +/- 5 vs 13 +/- 12 min, p less than 0.05), but not to S (10 +/- 6, p = NS) although not every patient had a cramp episode during each 2 week period of study. In a subgroup of 11 patients with a mean of 3.7 (range 1-6) cramps during each 2 week period, the efficacy of D, M, and S was similar. In both patient groups, IDWG, blood pressure control, and the frequency of adverse effects was similar with the use of all three agents. Mild postdialysis hyperglycemia and hypernatremia during D and S, respectively, were the only significant laboratory abnormalities. The authors conclude: 1) the safety and efficacy of D, M, and S are equivalent, and 2) the nonmetabolized osmotic agents M and S do not lead to increased IDWG or decreased blood pressure control.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>1768504</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0889-7190 |
ispartof | ASAIO transactions, 1991-10, Vol.37 (4), p.649-652 |
issn | 0889-7190 2375-0952 |
language | eng |
recordid | cdi_proquest_miscellaneous_72604755 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Pressure - drug effects Double-Blind Method Emergency and intensive care: renal failure. Dialysis management Female Glucose Solution, Hypertonic - therapeutic use Humans Intensive care medicine Male Mannitol - therapeutic use Medical sciences Middle Aged Muscle Cramp - drug therapy Muscle Cramp - epidemiology Muscle Cramp - etiology Prospective Studies Renal Dialysis - adverse effects Saline Solution, Hypertonic - therapeutic use Weight Gain - drug effects |
title | Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%2050%25%20dextrose%20water,%2025%25%20mannitol,%20and%2023.5%25%20saline%20for%20the%20treatment%20of%20hemodialysis-associated%20muscle%20cramps&rft.jtitle=ASAIO%20transactions&rft.au=CANZANELLO,%20V.%20J&rft.date=1991-10&rft.volume=37&rft.issue=4&rft.spage=649&rft.epage=652&rft.pages=649-652&rft.issn=0889-7190&rft.eissn=2375-0952&rft.coden=ASATEJ&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72604755%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72604755&rft_id=info:pmid/1768504&rfr_iscdi=true |